Oral mucositis is a costly consequence of cancer therapy that can impede the efficacy of anticancer therapy. Simple preventive measures can greatly improve the patient�s outcome and quality of life.
By James Radke, PhD
Advertisement
Articles by By James Radke, PhD
Advertisement
Latest Updated Articles
- The Management of Oral Mucositis in Oncology
June 8th 2010
Advertisement
Advertisement
Trending on OncLive
1
In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas
2
Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC
3
Experts Weigh In on Some of the Most Impactful Data in Melanoma From ASCO 2026
4
Emiltatug Ledadotin Elicits Responses in Aggressive Adenoid Cystic Carcinoma
5